Trials / Withdrawn
WithdrawnNCT00862472
Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate that the IOP-lowering efficacy of DuoTrav APS, dosed once-daily in the morning, is non-inferior to that of DuoTrav, dosed once-daily in the morning.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DuoTrav APS | DuoTrav APS QD AM |
| DRUG | DuoTrav | DuoTrav QD AM |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-03-17
- Last updated
- 2012-01-18
Source: ClinicalTrials.gov record NCT00862472. Inclusion in this directory is not an endorsement.